I think that the S&N agreement was made under the previous CEO .
Bone void filler is Possibly one of PNV's best products , but unfortunately when PNV made this agreement we would not have been a comanding position , being a low cap company without a great deal of cash , so it would not have been in our favour .
By challenging S&Ns inaction on the bone void filler in court , we could meet a fate the same as phosphagenics "BROKE " .
Better to let it slide and concentrate on our other products and keep full control of them .
At least PNV is not a one trick pony , with plenty of products to look forward to ,
I think PNV will become one of australia's premier companies .
Ann: Appendix 3B Leon Hoare, page-21
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.005(0.19%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.61 | $2.57 | $945.6K | 365.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 43983 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 20780 | 31 |
View Market Depth
| Last trade - 14.19pm 20/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |